Table 4.
Characteristic | N | % |
---|---|---|
Programs offering nPEP | 106 | 63 |
Medication regimens | ||
Efavirenz plus (lamivudine or emtricitabine) plus (zidovudine or tenofovir) | 26 | 27 |
Lopinavir/ritonavir plus (lamivudine or emtricitabine) plus zidovudine | 41 | 43 |
Other CDC regimen | 6 | 6 |
Consult a specialist | 11 | 12 |
Risk-determined regimen (e.g., high-risk exposure receives 3 medications versus 2) | 4 | 4 |
Other medication regimen | 7 | 7 |
Days of nPEP Supplied | ||
< 3 days | 4 | 4 |
3–5 days | 45 | 46 |
1st week | 12 | 12 |
28 days | 16 | 16 |
prescription only | 15 | 15 |
no meds or alternate methods of provision | 6 | 6 |
Programs not offering nPEP | 63 | 37 |
Patient referred elsewhere for HIV related care | ||
Yes | 61 | 95 |
No | 3 | 5 |
Patient referred to: | ||
Health Department/Free Clinic | 20 | 33 |
HIV Clinic | 18 | 30 |
Primary Care Physician | 13 | 22 |
Emergency Department | 4 | 7 |
Infectious Disease Specialist | 4 | 7 |
Other | 1 | 2 |
Note. nPEP = non-occupational post exposure prophylaxis; SANE = Sexual Assault Nurse Examiner; FNE = Forensic Nurse Examiner; CDC = Centers for Disease Control and Prevention